Insecticides India Reports Q3FY26 Results, Declares ₹2 Interim Dividend
Insecticides (India) Limited reported Q3FY26 standalone revenue of ₹38,356.38 lacs and net profit of ₹884.30 lacs. The company declared an interim dividend of ₹2 per share with record date February 6, 2026. Nine-month revenue grew 4.45% to ₹1,71,618.51 lacs, while the company completed dissolution of its Dubai subsidiary.

*this image is generated using AI for illustrative purposes only.
Insecticides (India) Limited has announced its unaudited financial results for the third quarter ended December 31, 2025, alongside declaring an interim dividend for shareholders. The agro-chemicals manufacturer's Board of Directors approved the results at their meeting held on January 30, 2026.
Q3FY26 Financial Performance
The company's standalone performance for Q3FY26 showed mixed results compared to the previous year. Revenue from operations reached ₹38,356.38 lacs, representing a 6.78% increase from ₹35,922.71 lacs in Q3FY24. However, net profit declined to ₹884.30 lacs from ₹1,500.14 lacs in the corresponding quarter last year.
| Metric: | Q3FY26 | Q3FY25 | Q3FY24 |
|---|---|---|---|
| Revenue from Operations: | ₹38,356.38 lacs | ₹64,124.89 lacs | ₹35,922.71 lacs |
| Net Profit: | ₹884.30 lacs | ₹5,531.02 lacs | ₹1,500.14 lacs |
| Basic EPS: | ₹3.04 | ₹19.01 | ₹5.15 |
| Total Income: | ₹38,445.26 lacs | ₹64,392.33 lacs | ₹35,943.63 lacs |
Nine Months Performance
For the nine months ended December 31, 2025, the company demonstrated resilient performance with revenue from operations of ₹1,71,618.51 lacs compared to ₹1,64,312.07 lacs in the corresponding period last year. Net profit for the nine-month period stood at ₹12,145.37 lacs versus ₹12,574.07 lacs in the previous year.
| Parameter: | 9M FY26 | 9M FY25 |
|---|---|---|
| Revenue Growth: | 4.45% | - |
| Nine-month EPS: | ₹41.74 | ₹42.71 |
| Total Expenses: | ₹1,56,021.88 lacs | ₹1,47,937.75 lacs |
Consolidated Results
On a consolidated basis, the company reported revenue from operations of ₹38,491.62 lacs for Q3FY26, with net profit of ₹1,048.82 lacs. The consolidated nine-month revenue reached ₹1,71,375.02 lacs with profit of ₹12,770.11 lacs, including share of profit from joint venture OAT & IIL India Laboratories Private Limited.
Interim Dividend Declaration
The Board declared an interim dividend of ₹2.00 per equity share, representing 20% on the face value of ₹10 per share for financial year 2025-26. Key dividend details include:
| Dividend Details: | Information |
|---|---|
| Dividend Amount: | ₹2.00 per share |
| Record Date: | February 6, 2026 |
| Payment Date: | On or after February 11, 2026 |
| Face Value: | ₹10 per share |
Corporate Updates
The company completed the dissolution of its wholly owned subsidiary IIL Overseas DMCC, Dubai, which was approved by the Board in August 2024. The dissolution was formally approved by DMCCA on September 19, 2025. Additionally, the company continues to monitor the implementation of India's New Labour Codes, which became effective from November 21, 2025, though no incremental liability is estimated at present.
Historical Stock Returns for Insecticides
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -7.96% | -5.60% | -15.55% | -44.11% | -6.11% | +83.62% |


































